Proteome Sciences plc PI2.F Stock
Proteome Sciences plc Price Chart
Proteome Sciences plc PI2.F Financial and Trading Overview
Proteome Sciences plc stock price | 0.04 EUR |
Previous Close | 0.06 EUR |
Open | 0.06 EUR |
Bid | 0.06 EUR x 1400000 |
Ask | 0.09 EUR x 1099500 |
Day's Range | 0.06 - 0.06 EUR |
52 Week Range | 0.02 - 0.06 EUR |
Volume | 1K EUR |
Avg. Volume | 17 EUR |
Market Cap | 18.81M EUR |
Beta (5Y Monthly) | -0.059386 |
PE Ratio (TTM) | 5.5 |
EPS (TTM) | -0.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PI2.F Valuation Measures
Enterprise Value | 25.93M EUR |
Trailing P/E | 5.5 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.418275 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 3.333 |
Enterprise Value/EBITDA | 14.137 |
Trading Information
Proteome Sciences plc Stock Price History
Beta (5Y Monthly) | -0.059386 |
52-Week Change | 121.81% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.06 EUR |
52 Week Low | 0.02 EUR |
50-Day Moving Average | 0.04 EUR |
200-Day Moving Average | 0.03 EUR |
PI2.F Share Statistics
Avg. Volume (3 month) | 17 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 295.18M |
Float | 117.61M |
Short Ratio | N/A |
% Held by Insiders | 21.48% |
% Held by Institutions | 23.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 17.03% |
Operating Margin (ttm) | 22.21% |
Gross Margin | 61.27% |
EBITDA Margin | 23.57% |
Management Effectiveness
Return on Assets (ttm) | 9.60% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 7.78M EUR |
Revenue Per Share (ttm) | 0.03 EUR |
Quarterly Revenue Growth (yoy) | 43.60% |
Gross Profit (ttm) | N/A |
EBITDA | 1.83M EUR |
Net Income Avi to Common (ttm) | 1.33M EUR |
Diluted EPS (ttm) | 0.01 |
Quarterly Earnings Growth (yoy) | 153.90% |
Balance Sheet
Total Cash (mrq) | 3.99M EUR |
Total Cash Per Share (mrq) | 0.01 EUR |
Total Debt (mrq) | 11.92M EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.552 |
Book Value Per Share (mrq) | -0.003 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.14M EUR |
Levered Free Cash Flow (ttm) | 434.38K EUR |
Profile of Proteome Sciences plc
Country | Germany |
State | N/A |
City | Cobham |
Address | Coveham House |
ZIP | KT11 3EP |
Phone | 44 20 7043 2116 |
Website | https://www.proteomics.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Q&A For Proteome Sciences plc Stock
What is a current PI2.F stock price?
Proteome Sciences plc PI2.F stock price today per share is 0.04 EUR.
How to purchase Proteome Sciences plc stock?
You can buy PI2.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Proteome Sciences plc?
The stock symbol or ticker of Proteome Sciences plc is PI2.F.
Which industry does the Proteome Sciences plc company belong to?
The Proteome Sciences plc industry is Diagnostics & Research.
How many shares does Proteome Sciences plc have in circulation?
The max supply of Proteome Sciences plc shares is 295.18M.
What is Proteome Sciences plc Price to Earnings Ratio (PE Ratio)?
Proteome Sciences plc PE Ratio is now.
What was Proteome Sciences plc earnings per share over the trailing 12 months (TTM)?
Proteome Sciences plc EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Proteome Sciences plc company belong to?
The Proteome Sciences plc sector is Healthcare.